Document is current
Any future updates will be listed below
-
Authors
Duffy, Áine
Chen, Robert
Stein, David https://orcid.org/0000-0002-5131-8313
Park, Joshua K.
Mort, Matthew
Verbanck, Marie https://orcid.org/0000-0002-1669-572X
Schlessinger, Avner https://orcid.org/0000-0003-4007-7814
Itan, Yuval https://orcid.org/0000-0003-4966-3238
Cooper, David N. https://orcid.org/0000-0002-8943-8484
Jordan, Daniel M.
Rocheleau, Ghislain https://orcid.org/0000-0002-9989-7553
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35-GM124836)
- License Information
-
More Information
Article History
Received: 28 October 2024
Accepted: 27 August 2025
First Online: 30 September 2025
Competing interests
: R.D. reported being a scientific co-founder, consultant and equity holder for Pensieve Health (pending) and being a consultant for Variant Bio and Character Bio. A.D. is a current full-time employee of GlaxoSmithKline. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
